Real drug innovation

Today, the FDA approved telapravir for Hep C.  That’s happy news at Vertex (and Merck last week) but an all-too-rare story of new drugs meeting significant human health needs.

More like this, please.

Share on twitter
Share on facebook
Share on linkedin
Share on reddit
Share on email

Hidden information below

Subscribe

* indicates required
Email Format